Tenomix: Scaling an Artificial Intelligence-Powered Cancer Solution
商品編號：W47986
出版日期：2026/02/12
再版日期：2026/04/30
商品來源：
商品主題：Entrepreneurship; Strategy
商品類型：Case (Field)
涵蓋議題：Artificial intelligence (AI);Medical innovation;Cancer diagnostics;Health technology;AI in healthcare;Pathology workflow;Go-to-market strategy;Data governance
難易度：4 - Undergraduate/MBA
內容長度：11 頁
地域：Canada
產業：Health Care Services
事件年度：2025
Tenomix Inc., a Canadian medical technology startup, developed the Lymphonator—a semi-automated device that used robotics, ultrasound imaging, and artificial intelligence (AI) to identify lymph nodes in colorectal cancer specimens. After securing early funding and prototype validation with hospitals, the chief executive officer, Saumik Biswas, must choose a go-to-market model to scale: flat-rate pricing, perpetual licensing, or subscription. His decision will shape Tenomix’s valuation, investor confidence, hospital adoption, and the company’s ability to expand into new cancer applications while navigating evolving AI and data-privacy regulations.
教學手冊：Tenomix: Scaling an Artificial Intelligence-Powered Cancer Solution - Teaching Note
補充材料：